The two main branches associated with Artificial Intelligence (AI) in medicine are virtual and physical. The virtual component includes machine learning (ML) and algorithms, whereas physical AI includes medical devices and robots for delivering care. AI is used successfully in tumour segmentation, histopathological diagnosis, tracking tumour development, and prognosis prediction. CURATE.AI, developed at the National University of Singapore, is a platform that automatically decides the optimum dose of drugs for a durable response, allowing the patient to resume a completely normal life. With the involvement of technology multinationals, such as Google and Microsoft, in AI and healthcare in association with leading healthcare companies, the future of AI in healthcare looks very promising.

医学中与人工智能（AI）相关的两个主要分支是虚拟的和物理的。虚拟组件包括机器学习（ML）和算法，而物理AI包括医疗设备和用于提供护理的机器人。AI已成功用于肿瘤分割，组织病理学诊断，跟踪肿瘤发展和预后预测。由新加坡国立大学开发的CURATE.AI是一个平台，可自动确定最佳药物剂量以产生持久反应，使患者恢复完全正常的生活。随着领先的医疗保健公司与Google和Microsoft等技术跨国公司的参与，人工智能和医疗保健领域的AI前景十分广阔。